Product News and Recalls

Lopez McHugh IVC Trial Ends With Settlement

On January 26, 2015, Lopez McHugh represented a plaintiff in the second lawsuit in the nation to proceed to trial against Bard for its defective inferior vena cava filters. Ramon Rossi Lopez and Troy Brenes were lead trial counsel in the case, which involved a Recovery Filter that migrated to and punctured a hole in the plaintiff’s heart, leading to emergency open heart surgery. After 11 days of trial, Bard made a confidential settlement offer, ...

continue reading...

4 Things You Absolutely Need to Know About Lipitor Lawsuits

link established between lipitor and diabetesAs evidence continues to mount proving Lipitor’s role in causing Type II diabetes in women, questions continue to surface about how to file a Lipitor lawsuit.

The cholesterol-reduction drug has been on the market since 1996 and millions of prescriptions have been written each year since. It wasn’t until 2012, however, that the Food and Drug Administration began raising alarms about a possible link between Lipitor and diabetes, particularly among female patients.

There is ...

continue reading...

Daiichi Sankyo to Pay $39 Million to Settle Kickback Claims After Whistleblower Lawsuit

Daiichi Sankyo Co Ltd, a global pharmaceutical company, is being forced to pay $39 million to the United States government and state Medicaid programs to settle claims that the company paid doctors kickbacks to prescribe its drugs. Reuters reported that the fine was negotiated with the Department of Justice based on a whistleblower case by a former sales representative.

The lawsuit alleged that Daiichi paid doctors kickbacks from 2004 to 2011 to endorse the company’s various pharmaceutical ...

continue reading...

FDA Drug Approvals Hit 18 Year High

In 2014, the FDA Center for Drug Evaluation and Research approved the most drugs since 1996. The FDA approved 41 novel medications last year, 62% more than the 27 approved in 2013. The only year that topped 2014 was 1996, when 53 new drugs were approved.

The new drug approvals consisted mostly of innovative, expensive treatments where competition is limited and costs of treatment can often exceed $100,000 per patient per year. Infectious disease drugs received ...

continue reading...

4 Patients Sickened by Contaminated Duodenoscopes

hospital-acquired infections are on the riseFour patients have acquired infections from antibiotic-resistant bacteria at Cedars-Sinai Medical Center in Los Angeles, according to an article by the Science Times. The discovery comes two weeks after two patients died and an unknown number were infected at the Ronald Reagan UCLA Medical Center. All six patients were likely infected by contaminated duodenoscopes.

The hospital-acquired infections were reportedly caused by the same “superbug” that broke out at the UCLA ...

continue reading...

Xarelto Lawsuit Filed in Rhode Island

xarelto lawsuit filed as deaths continue to increaseA Rhode Island man has filed a Xarelto lawsuit against multiple pharmaceutical companies for injuries related to the drug. The plaintiff claimed that the defendants, including Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, received a letter from the FDA in 2013 requesting that they stop improper promotion of their product. The plaintiff further claimed that there is no antidote to the blood-thinning properties of Xarelto, in the event ...

continue reading...
Page 1 of 222 12345...»